Search

Your search keyword '"Lecour, S"' showing total 126 results

Search Constraints

Start Over You searched for: Author "Lecour, S" Remove constraint Author: "Lecour, S" Database MEDLINE Remove constraint Database: MEDLINE
126 results on '"Lecour, S"'

Search Results

1. Interplay between the SAFE and the sphingolipid pathway for cardioprotection.

2. Cardioprotection with Intralipid During Coronary Artery Bypass Grafting Surgery on Cardiopulmonary Bypass: A Randomized Clinical Trial.

3. Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial.

4. People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case-control study.

5. Doxorubicin-induced cardiotoxicity and risk factors.

6. Role of nuclear factor kappa-B in TNF-induced cytoprotection.

7. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.

8. Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart.

11. Redox Regulatory Changes of Circadian Rhythm by the Environmental Risk Factors Traffic Noise and Air Pollution.

12. RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.

13. Circadian rhythms in ischaemic heart disease: key aspects for preclinical and translational research: position paper of the ESC working group on cellular biology of the heart.

14. Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?

15. Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop.

16. Time and Conditioning.

17. IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action.

18. COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart.

19. Chronic and moderate consumption of reduced-alcohol wine confers cardiac benefits in a rat model of pulmonary arterial hypertension.

20. Decreased Human Leukocyte Antigen DR on Circulating Monocytes Expression After Severe Pediatric Trauma: An Exploratory Report.

21. Melatonin against pulmonary arterial hypertension: is it ready for testing in patients?

23. Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart.

24. Analysis of the regenerative capacity of human serum exosomes after a simple multistep separation from lipoproteins.

25. Hyperlipidaemia and cardioprotection: Animal models for translational studies.

26. Influence of mental stress and environmental toxins on circadian clocks: Implications for redox regulation of the heart and cardioprotection.

27. HIV-related cardiovascular disease: any role for high-density lipoproteins?

28. Linking LOXL2 to Cardiac Interstitial Fibrosis.

29. Identification of potential biomarkers for predicting the early onset of diabetic cardiomyopathy in a mouse model.

32. Hypertension in a resource-limited setting: Poor Outcomes on Short-term Follow-up in an Urban Hospital in Maputo, Mozambique.

34. HDL protects against myocardial ischemia reperfusion injury via miR-34b and miR-337 expression which requires STAT3.

36. HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations.

37. The impact of sugar-sweetened beverage intake on rat cardiac function.

38. ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure.

39. HDL Subclass Distribution Shifts with Increasing Central Adiposity.

40. The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection-evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology.

41. Exercise intervention alters HDL subclass distribution and function in obese women.

42. Vasculature on the clock: Circadian rhythm and vascular dysfunction.

43. Cardiovascular Benefits of Dietary Melatonin: A Myth or a Reality?

44. An Exercise Intervention to Unravel the Mechanisms Underlying Insulin Resistance in a Cohort of Black South African Women: Protocol for a Randomized Controlled Trial and Baseline Characteristics of Participants.

45. Sphingosine-1-phosphate (S1P) activates STAT3 to protect against de novo acute heart failure (AHF).

46. Pharmacological Intervention to Modulate HDL: What Do We Target?

47. The SAFE pathway for cardioprotection: is this a promising target?

48. Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology.

49. Melatonin as a cardioprotective therapy following ST-segment elevation myocardial infarction: is it really promising? Reply.

50. Soluble ST2 correlates with some indicators of right ventricular function in hypertensive heart failure.

Catalog

Books, media, physical & digital resources